Evidence map›Paper›PMID 27154353›Full record

ArticleJournal of leukocyte biology2016

Odorants specifically modulate chemotaxis and tissue retention of CD4+ T cells via cyclic adenosine monophosphate induction.

Adam A Clark, Saule Nurmukhambetova, Xin Li, Steven D Munger, Jason R Lees

Open access · bronzeAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. NAD activates olfactory receptor 1386 to regulate type I interferon responses inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Olfactory receptors contribute to progression of kidney fibrosis.NPJ systems biology and applications · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Adam A ClarkDepartment of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Saule NurmukhambetovaDepartment of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Xin LiDepartment of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Steven D MungerDepartment of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, Maryland, USA; Department of Medicine, Division of Endocrinology, Diabetes and Nutrition, University of Maryland School of Medicine, Baltimore, Maryland, USA; and.
Jason R LeesDepartment of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA jason.lees@usuhs.edu.
University of Maryland, Baltimore · USUniformed Services University of the Health Sciences · US

Funding

Transduction mechanisms and CNS targets of GC-D neuronsR01DC005633 · NIDCD · UNIVERSITY OF MARYLAND BALTIMORE · PI MUNGER, STEVEN D · 2003 to 2014
$3.5M
NIDCD NIH HHS R01 DC005633
6 · The paper itself

Abstract

Retention of T cells within affected tissue is a critical component of adaptive immune inflammation. However, the mechanisms involved in T cell retention remain largely undefined. Previous studies revealed the capacity of cAMP signaling to regulate immune cell migration, as well as dynamic regulation of receptors that could induce cAMP production in immune cells. The potential for cAMP to act as a retention signal has been mostly unexplored, partially as a result of this second messenger's well-characterized inhibition of effector function in immune cells. Here, we report that cAMP regulates the tissue retention of mouse T cells at concentrations well below those that inhibited proliferation or decreased acquisition of an effector phenotype. Stimulation of CD4

Indexed as

OdorantsAdaptive ImmunityAnimalsAnimals, CongenicAntigens, CDAntigens, Differentiation, T-LymphocyteCD4-Positive T-LymphocytesCD69 AntigensCell Line, TumorCells, CulturedChemokine CCL21Chemokine CXCL12Chemotaxis, LeukocyteColforsinCyclic AMPDicarboxylic Acids3-(5-tert-butylisoxazol-3-yl)-2-((3-chlorophenyl)hydrazono)-3-oxopropionitrile5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole-3',5'-monophosphorothioateAntigens, CDAntigens, Differentiation, T-Lymphocyteazelaic acidCD69 AntigensChemokine CCL21Chemokine CXCL12ColforsinCyclic AMPDicarboxylic AcidsDichlororibofuranosylbenzimidazoleFatty AcidsHydrazonesIsoxazolesLectins, C-Typepelargonic acidReceptors, OdorantThionucleotidescell traffickingextranasalinflammation

Identifiers

PMID27154353
PMCPMC5014743
OpenAlexW2347118185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.